ETRM

Enteromedics (ETRM)

Enteromedics

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ETRM

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2017/10/24	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ETRM	Enteromedics
2017/10/23	21 : 30	PR Newswire (US)	EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)	NASDAQ:ETRM	Enteromedics
2017/10/18	05 : 15	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:ETRM	Enteromedics
2017/10/16	21 : 00	PR Newswire (US)	EnteroMedics Announces Presentations at ObesityWeek 2017	NASDAQ:ETRM	Enteromedics
2017/10/13	07 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ETRM	Enteromedics
2017/10/13	07 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ETRM	Enteromedics
2017/10/13	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ETRM	Enteromedics
2017/10/13	05 : 52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ETRM	Enteromedics
2017/10/13	05 : 46	PR Newswire (US)	EnteroMedics Announces New Employee Inducement Option Grants	NASDAQ:ETRM	Enteromedics
2017/10/06	22 : 04	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ETRM	Enteromedics
2017/10/03	21 : 48	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ETRM	Enteromedics
2017/10/03	21 : 47	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ETRM	Enteromedics
2017/10/03	21 : 30	PR Newswire (US)	EnteroMedics Announces Acquisition Of ReShape Medical	NASDAQ:ETRM	Enteromedics
2017/09/12	21 : 30	PR Newswire (US)	EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference	NASDAQ:ETRM	Enteromedics
2017/09/06	05 : 15	PR Newswire (US)	EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy	NASDAQ:ETRM	Enteromedics
2017/08/29	05 : 05	PR Newswire (US)	Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective	NASDAQ:ETRM	Enteromedics
2017/08/25	06 : 02	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:ETRM	Enteromedics
2017/08/21	22 : 00	PR Newswire (US)	EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland	NASDAQ:ETRM	Enteromedics
2017/08/17	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ETRM	Enteromedics
2017/08/16	22 : 00	PR Newswire (US)	EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference	NASDAQ:ETRM	Enteromedics
2017/08/16	05 : 10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ETRM	Enteromedics
2017/08/12	05 : 15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ETRM	Enteromedics
2017/08/11	21 : 20	PR Newswire (US)	EnteroMedics Announces Pricing of $20 Million Underwritten Public Offering	NASDAQ:ETRM	Enteromedics
2017/08/11	21 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ETRM	Enteromedics
2017/08/11	05 : 34	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ETRM	Enteromedics
2017/08/11	05 : 34	PR Newswire (US)	EnteroMedics Announces Proposed Underwritten Public Offering	NASDAQ:ETRM	Enteromedics
2017/08/09	05 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ETRM	Enteromedics
2017/08/08	21 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ETRM	Enteromedics
2017/08/08	20 : 00	PR Newswire (US)	EnteroMedics Announces Second Quarter 2017 Financial Results	NASDAQ:ETRM	Enteromedics
2017/08/02	20 : 00	PR Newswire (US)	EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017	NASDAQ:ETRM	Enteromedics